Биомаркеры острого коронарного синдрома: от истоков до наших дней

1. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-69. DOI:10.1093/eurheartj/ehy462
2. LaDue JS, Wroblewski F, Karmen A Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954;120:497-9. DOI:10.1126/science.120.3117.497
3. World Health Organization Expert Committee. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. First report of the expert committee on cardiovascular diseases and hypertension. WHO Tech Rep Ser. 1959;168.
4. Dreyfus JC, Schapira G, Rasnais J, et al. Serum creatine kinase in the diagnosis of myocardial infarct. Rev Fr Etud Clin Biol. 1960;5:386-7.
5. Roberts R, Sobel BE, Parker CW. Radioimmunoassay for creatine kinase isoenzymes. Science. 1976;194:855-7. DOI: 10.1126/science.982049
6. World Health Organization. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 1979;59:607-9. DOI:10.1161/01.cir.59.3.607
7. Danese E, Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med. 4:194. DOI:10.21037/atm.2016.05.19
8. Ebashi S. Third component participating in the superprecipitation of ‘natural actomyosin’. Nature. 1963;200:1010. DOI:10.1038/2001010a0
9. Greaser ML, Gergely J. Reconstitution of troponin activity from three protein components. J Biol Chem. 1971;246:4226-33. DOI:10.1016/S0021-9258(18)62075-7
10. Bucher EA, Maisonpierre PC, Konieczny SF, et al. Expression of the troponin complex genes: transcriptional coactivation during myoblast differentiation and independent control in heart and skeletal muscles. Mol Cell Biol. 1988;8:4134-42. DOI:10.1128%2Fmcb.8.10.4134
11. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113:1333-44. DOI:10.1016/0002-8703(87)90645-4
12. Müller-Bardorff M, Hallermeyer K, Schroder A, et al. Improved Troponin T ELISA specific for cardiac Troponin T isoform: assay development and analytical and clinical validation. Clin Chem. 1997;43:458-66.
13. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. Scand J Clin Lab Invest. Suppl. 1999;230:128-31.
14. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254-61. DOI:10.1373/clinchem.2009.132654
15. Zhelev Z, Hyde C, Youngman E, et al. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis BMJ. 2015;350:h15. DOI:10.1136/bmj.h15
16. Røysland R, Kravdal G, Høiseth AD, et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin Sci (Lond). 2012;122(12):599-606. DOI:10.1042/CS20110557
17. Jeremias A, Gibson CM. Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded. Ann Intern Med.
2005;142:786-91. DOI:10.7326/0003-4819-142-9-200505030-00015
18. Garg P, Morris P, Fazlanie AL, et al. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017;12(2):147-55. DOI:10.1007/s11739-017-1612-1
19. Миронова О.Ю., Бердышева М.В., Елфимова Е.М. МикроРНК: взгляд клинициста на состояние проблемы. Часть 2. МикроРНК в качестве биомаркера. Евразийский Кардиологический Журнал. 2023;(2):64-71 [Mironova OI, Berdysheva MV, Elfimova EM. MicroRNA: a clinician’s view of the state of the problem. Part 2. MicroRNA as a biomarker. Eurasian Heart Journal. 2023;(2):64-71 (in Russian)]. DOI:10.38109/2225-1685-2023-2-64-71
20. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659-66. DOI:10.1093/eurheartj/ehq013
21. Wang X, Tian L, Sun Q. Diagnostic and prognostic value of circulating miRNA-499 and miRNA-22 in acute myocardial infarction. J Clin Lab Anal. 2020;34(8):2410-7. DOI:10.1002/jcla.23332
22. Shi S, Yi JL. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα. Eur Rev Med Pharmacol Sci. 2018;22(12):3925-35. DOI:10.26355/eurrev_201806_15278
23. Li Y, Chen B, Yang X, et al. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Circulation. 2019;140(9):751-64. DOI:10.1161/CIRCULATIONAHA.118.039262
24. Singh N, Rathore V, Mahat RK, Rastogi P. Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction. Indian J Clin Biochem. 2018;33(3):356-60. DOI:10.1007/s12291-017-0685-y

________________________________________________

1. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-69. DOI:10.1093/eurheartj/ehy462
2. LaDue JS, Wroblewski F, Karmen A Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954;120:497-9. DOI:10.1126/science.120.3117.497
3. World Health Organization Expert Committee. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. First report of the expert committee on cardiovascular diseases and hypertension. WHO Tech Rep Ser. 1959;168.
4. Dreyfus JC, Schapira G, Rasnais J, et al. Serum creatine kinase in the diagnosis of myocardial infarct. Rev Fr Etud Clin Biol. 1960;5:386-7.
5. Roberts R, Sobel BE, Parker CW. Radioimmunoassay for creatine kinase isoenzymes. Science. 1976;194:855-7. DOI: 10.1126/science.982049
6. World Health Organization. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 1979;59:607-9. DOI:10.1161/01.cir.59.3.607
7. Danese E, Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med. 4:194. DOI:10.21037/atm.2016.05.19
8. Ebashi S. Third component participating in the superprecipitation of ‘natural actomyosin’. Nature. 1963;200:1010. DOI:10.1038/2001010a0
9. Greaser ML, Gergely J. Reconstitution of troponin activity from three protein components. J Biol Chem. 1971;246:4226-33. DOI:10.1016/S0021-9258(18)62075-7
10. Bucher EA, Maisonpierre PC, Konieczny SF, et al. Expression of the troponin complex genes: transcriptional coactivation during myoblast differentiation and independent control in heart and skeletal muscles. Mol Cell Biol. 1988;8:4134-42. DOI:10.1128%2Fmcb.8.10.4134
11. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113:1333-44. DOI:10.1016/0002-8703(87)90645-4
12. Müller-Bardorff M, Hallermeyer K, Schroder A, et al. Improved Troponin T ELISA specific for cardiac Troponin T isoform: assay development and analytical and clinical validation. Clin Chem. 1997;43:458-66.
13. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. Scand J Clin Lab Invest. Suppl. 1999;230:128-31.
14. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254-61. DOI:10.1373/clinchem.2009.132654
15. Zhelev Z, Hyde C, Youngman E, et al. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis BMJ. 2015;350:h15. DOI:10.1136/bmj.h15
16. Røysland R, Kravdal G, Høiseth AD, et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin Sci (Lond). 2012;122(12):599-606. DOI:10.1042/CS20110557
17. Jeremias A, Gibson CM. Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded. Ann Intern Med.
2005;142:786-91. DOI:10.7326/0003-4819-142-9-200505030-00015
18. Garg P, Morris P, Fazlanie AL, et al. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017;12(2):147-55. DOI:10.1007/s11739-017-1612-1
19. Mironova OI, Berdysheva MV, Elfimova EM. MicroRNA: a clinician’s view of the state of the problem. Part 2. MicroRNA as a biomarker. Eurasian Heart Journal. 2023;(2):64-71 (in Russian). DOI:10.38109/2225-1685-2023-2-64-71
20. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659-66. DOI:10.1093/eurheartj/ehq013
21. Wang X, Tian L, Sun Q. Diagnostic and prognostic value of circulating miRNA-499 and miRNA-22 in acute myocardial infarction. J Clin Lab Anal. 2020;34(8):2410-7. DOI:10.1002/jcla.23332
22. Shi S, Yi JL. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα. Eur Rev Med Pharmacol Sci. 2018;22(12):3925-35. DOI:10.26355/eurrev_201806_15278
23. Li Y, Chen B, Yang X, et al. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Circulation. 2019;140(9):751-64. DOI:10.1161/CIRCULATIONAHA.118.039262
24. Singh N, Rathore V, Mahat RK, Rastogi P. Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction. Indian J Clin Biochem. 2018;33(3):356-60. DOI:10.1007/s12291-017-0685-y

Е.А. Окишева*, О.Ю. Трушина

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*e.okisheva@gmail.com

________________________________________________

Elena A. Okisheva*, Olga Iu. Trushina

Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*e.okisheva@gmail.com